Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Riley E Perszyk

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Molecular Pharmacology|February 19, 2026
A subunit-selective negative allosteric modulator of GluN1/GluN3A glycine-activated receptorLeon Jacobs, TrangKimberly T Nguyen, Adam McCallum, et al.
Epilepsia|January 5, 2026
Memantine treatment in individuals with GRIN gain-of-function variants is associated with improvements in behavior, development, and seizure frequencyMaike Karnstedt, Riley E Perszyk, Scott J Myers, et al.
Cellular and Molecular Life Sciences : CMLS|March 31, 2023
Functional effects of disease-associated variants reveal that the S1-M1 linker of the NMDA receptor critically controls channel openingLingling Xie, Miranda J McDaniel, Riley E Perszyk, et al.
Nature Chemical Biology|January 22, 2020
Biased modulators of NMDA receptors control channel opening and ion selectivityRiley E Perszyk, Sharon A Swanger, Chris Shelley, et al.
Pharmacological Reviews|November 10, 2021
Structure, Function, and Pharmacology of Glutamate Receptor Ion ChannelsKasper B Hansen, Lonnie P Wollmuth, Derek Bowie, et al.
ACS Chemical Neuroscience|December 16, 2020
Distinct GluN1 and GluN2 Structural Determinants for Subunit-Selective Positive Allosteric Modulation of <i>N</i>-Methyl-d-aspartate ReceptorsKatie L Strong, Matthew P Epplin, Kevin K Ogden, et al.
Brain : a Journal of Neurology|September 25, 2025
Inhibition of GluN2B-containing N-methyl-d-aspartate receptors by radiprodilTue G Banke, Michael C Regan, Riley E Perszyk, et al.
Cellular and Molecular Life Sciences : CMLS|November 3, 2023
Clinical and functional consequences of GRIA variants in patients with neurological diseasesWenshu XiangWei, Riley E Perszyk, Nana Liu, et al.
ACS Chemical Neuroscience|August 11, 2023
Development of a Dihydroquinoline-Pyrazoline GluN2C/2D-Selective Negative Allosteric Modulator of the <i>N</i>-Methyl-d-aspartate ReceptorMichael P D'Erasmo, Nicholas S Akins, Peipei Ma, et al.
Cellular and Molecular Life Sciences : CMLS|March 28, 2024
De novo GRIN variants in M3 helix associated with neurological disorders control channel gating of NMDA receptorYuchen Xu, Rui Song, Riley E Perszyk, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Molecular Pharmacology|February 19, 2026
A subunit-selective negative allosteric modulator of GluN1/GluN3A glycine-activated receptorLeon Jacobs, TrangKimberly T Nguyen, Adam McCallum, et al.
Epilepsia|January 5, 2026
Memantine treatment in individuals with GRIN gain-of-function variants is associated with improvements in behavior, development, and seizure frequencyMaike Karnstedt, Riley E Perszyk, Scott J Myers, et al.
Cellular and Molecular Life Sciences : CMLS|March 31, 2023
Functional effects of disease-associated variants reveal that the S1-M1 linker of the NMDA receptor critically controls channel openingLingling Xie, Miranda J McDaniel, Riley E Perszyk, et al.
Nature Chemical Biology|January 22, 2020
Biased modulators of NMDA receptors control channel opening and ion selectivityRiley E Perszyk, Sharon A Swanger, Chris Shelley, et al.
Pharmacological Reviews|November 10, 2021
Structure, Function, and Pharmacology of Glutamate Receptor Ion ChannelsKasper B Hansen, Lonnie P Wollmuth, Derek Bowie, et al.
ACS Chemical Neuroscience|December 16, 2020
Distinct GluN1 and GluN2 Structural Determinants for Subunit-Selective Positive Allosteric Modulation of <i>N</i>-Methyl-d-aspartate ReceptorsKatie L Strong, Matthew P Epplin, Kevin K Ogden, et al.
Brain : a Journal of Neurology|September 25, 2025
Inhibition of GluN2B-containing N-methyl-d-aspartate receptors by radiprodilTue G Banke, Michael C Regan, Riley E Perszyk, et al.
Cellular and Molecular Life Sciences : CMLS|November 3, 2023
Clinical and functional consequences of GRIA variants in patients with neurological diseasesWenshu XiangWei, Riley E Perszyk, Nana Liu, et al.
ACS Chemical Neuroscience|August 11, 2023
Development of a Dihydroquinoline-Pyrazoline GluN2C/2D-Selective Negative Allosteric Modulator of the <i>N</i>-Methyl-d-aspartate ReceptorMichael P D'Erasmo, Nicholas S Akins, Peipei Ma, et al.
Cellular and Molecular Life Sciences : CMLS|March 28, 2024
De novo GRIN variants in M3 helix associated with neurological disorders control channel gating of NMDA receptorYuchen Xu, Rui Song, Riley E Perszyk, et al.
Pageof 4